Abstract
Introduction
The so called "neurodegenerative Langerhans cell histiocytosis" (ND-LCH) is a rare and severe complication of LCH presenting as a progressive cerebellar ataxia associated with pyramidal tract signs, and cognitive impairment. MRI is the gold standard to investigate CNS lesions of ND-LCH but little is known about functional changes observed in this disease.
Objectives
To search for CNS metabolic changes in NDLCH.
Methods
Seven patients suffering from ND-LCH were investigated by 18F-FDG PET in this prospective study and compared with 21 healthy controls.
Results
ND-LCH patients demonstrated recurrent abnormalities including bilateral hypometabolism in the cerebellum, the basal ganglia (caudate nuclei), frontal cortex and, bilateral, a relatively increased metabolism in the amygdalae (p < 0.001). Functional changes in these anatomical regions may be detected in the absence of any apparent lesion on MRI.
Conclusions
ND-LCH demonstrates a recurrent 18F-FDG PET metabolic signature. Our results suggest that 18F-FDG PET might be a useful tool for an early diagnosis of ND-LCH before neuroradiologic abnormalities appear.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Donadieu J, Rolon MA, Thomas C, et al. (2004) Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr 144:344–350
The French Langerhans' Cell Histiocytosis Study Group (1996) A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 75:17–24
Carpentier MA, Maheut J, Grangeponte MC, Billard C, Santini JJ (1991) Disseminated cerebral histiocytosis X responding to vinblastine therapy: a case report. Brain Dev 13:193–195
Idbaih A, Hoang-Xuan K; Martin-Duverneuil N, Genereau T, Thomas C, Barthez MA, Donadieu J, and The French LCH STUDY GROUP (2004) Langerhans Cell Histiocytosis presenting with progressive cerebellar ataxia: a clinical and neuroradiological study of 13 cases. Neurology 62 (Suppl 5): A196–A197
Martin-Duverneuil N, Idbaih A, Hoang-Xuan K, Donadieu J, Genereau T, Guillevin R, Chiras J, and the French Langerhans Cell Histiocytosis Study Group (2006) MRI features of Neurodegenerative Langerhans Cell Histiocytosis. Eur Radiol 16:2074–2082
Prayer D, Grois N, Prosch H, Gadner H, Barkovich AJ (2004) HMR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am J Neuroradiol 25:880–891
Barthez MA, Araujo E, Donadieu J (2000) Langerhans Cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol 15:150–156
Grois N, Prayer D, Prosch H, Lassmann H (2005) Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128:829–838
Grois NG, Favara BE, Mostbeck GH, Prayer D (1998) Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12:287–305
Grois N, Barkovich AJ, Rosenau W, Ablin AR (1993) Central nervous system disease associated with Langerhans' cell histiocytosis. Am J Pediatr Hematol Oncol 15:245–254
Wells WM, Viola PV, Atsumi H, Nakajima S, Kikinis R (1996) Multi-modal volume registration by maximization of mutual information. Med Image Anal 1:35–51
Pluim JPW, Maintz JBA,Viergever MA (2003) Mutual information based registration of medical images: a survey. IEEE Trans Med Imaging 22:986–1004
Calming U, Bemstrand C, Mosskin M, Elander SS, Ingvar M, Henter JI (2002) 18-FDG PET scan in central nervous system Langerhans cell histiocytosis. J Pediatr 141:435–440
Birnbaum DC, Shields D, Lippe B, Perlman S, Phillipart M (1989) Idiopathic central diabetes insipidus followed by progressive spastic cerebral ataxia. Report of four cases. Arch Neurol 46:1001–1003
Poe LB, Dubowy RL, Hochhauser L, et al. (1994) Demyelinating and gliotic cerebellar lesions in Langerhans cell histiocytosis. AJNR Am J Neuroradiol 15:1921–1928
Polizzi A, Coghill S, McShane MA, Squier W (2002) Acute ataxia complicating Langerhans cell histiocytosis. Arch Dis Child 86:130–131
Manning L, Sellal F (2003) Hypothalamic amnesia and frontal lobe function disorders after langerhans cell histiocytosis. J Neurol Neurosurg Psychiatry 74:1348
Nanduri VR, Lillywhite L, Chapman C, Parry L, Pritchard J, Vargha-Khadem F (2003) Cognitive outcome of longterm survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study. J Clin Oncol 21:2961–2967
Whitsett SF, Kneppers K, Coppes MJ, Egeler RM (1999) Neuropsychologic deficits in children with Langerhans cell histiocytosis. Med Pediatr Oncol 33:486–492
Otsuka M, Ichiya Y,Kuwabara Y, et al. (1996) Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. J Neurol Sci 144:77–83
Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe RA (1988) Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol 24:399–406
Buchler T, Cervinek L, Belohlavek O, et al. (2005) Langerhans cell histiocytosis with central nervous system involvement: Follow-up by FDG-PET during treatment with cladribine. Pediatr Blood Cancer 44:286–288
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ribeiro, MJ., Idbaih, A., Thomas, C. et al. 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis. J Neurol 255, 575–580 (2008). https://doi.org/10.1007/s00415-008-0751-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0751-8